Cypress Wealth Services LLC Has $580,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Cypress Wealth Services LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,485 shares of the healthcare conglomerate’s stock after selling 129 shares during the period. Cypress Wealth Services LLC’s holdings in UnitedHealth Group were worth $580,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of UNH. OLD Mission Capital LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at about $439,000. Camden National Bank raised its holdings in UnitedHealth Group by 5.5% in the 4th quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after acquiring an additional 100 shares during the period. Hoylecohen LLC raised its holdings in UnitedHealth Group by 9.0% in the 1st quarter. Hoylecohen LLC now owns 1,149 shares of the healthcare conglomerate’s stock valued at $428,000 after acquiring an additional 95 shares during the period. Cubist Systematic Strategies LLC raised its holdings in UnitedHealth Group by 216.8% in the 1st quarter. Cubist Systematic Strategies LLC now owns 8,130 shares of the healthcare conglomerate’s stock valued at $3,025,000 after acquiring an additional 5,564 shares during the period. Finally, Bamco Inc. NY increased its holdings in shares of UnitedHealth Group by 39.2% during the first quarter. Bamco Inc. NY now owns 23,786 shares of the healthcare conglomerate’s stock worth $8,850,000 after purchasing an additional 6,700 shares during the period. Institutional investors and hedge funds own 86.20% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now directly owns 154,403 shares in the company, valued at approximately $64,347,450.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Stephen J. Hemsley sold 75,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 80,000 shares of company stock valued at $35,743,375. 0.55% of the stock is owned by company insiders.

Shares of NYSE:UNH traded up $5.94 on Tuesday, hitting $443.48. The company had a trading volume of 30,441 shares, compared to its average volume of 2,943,648. The firm’s 50-day simple moving average is $429.12 and its two-hundred day simple moving average is $417.57. UnitedHealth Group Incorporated has a 1 year low of $320.35 and a 1 year high of $466.00. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $417.69 billion, a price-to-earnings ratio of 27.14, a P/E/G ratio of 1.75 and a beta of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The firm had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period last year, the company posted $3.51 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 18.84 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a dividend yield of 1.31%. UnitedHealth Group’s payout ratio is 35.98%.

Several research firms recently issued reports on UNH. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 target price on the stock in a report on Wednesday, October 27th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $465.00 to $475.00 and gave the company an “outperform” rating in a research note on Friday, October 15th. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $488.00 to $499.00 and gave the stock an “overweight” rating in a research report on Friday, October 15th. Evercore ISI boosted their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a research report on Friday, October 15th. Finally, Mizuho boosted their target price on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. One equities research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $477.35.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.